Jump Financial, LLC Altimmune, Inc. Transaction History

Jump Financial, LLC

$4.56 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.5 - $8.1 $1.55 Million - $2.28 Million	-281,000 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$5.91 - $10.23 $1.15 Million - $1.99 Million	194,812 Added 226.03%	281,000 $1.87 Million
Q1 2024 May 13, 2024	BUY	$8.22 - $13.81 $620,840 - $1.04 Million	75,528 Added 708.52%	86,188 $877,000
Q4 2023 Oct 21, 2024	SELL	$2.14 - $11.62 $22,660 - $123,044	-10,589 Reduced 49.83%	10,660 $119,000
Q4 2023 Feb 07, 2024	BUY	$2.14 - $11.62 $22,812 - $123,869	10,660 New	10,660 $119,000
Q2 2023 Oct 21, 2024	SELL	$3.45 - $5.97 $922,705 - $1.6 Million	-267,451 Reduced 92.64%	21,249 $75,000
Q2 2023 Aug 07, 2023	SELL	$3.45 - $5.97 $922,705 - $1.6 Million	-267,451 Reduced 92.64%	21,249 $75,000
Q1 2023 Oct 21, 2024	BUY	$4.19 - $16.83 $32,263 - $129,590	7,700 Added 2.74%	288,700 $1.22 Million
Q1 2023 May 03, 2023	BUY	$4.19 - $16.83 $1.21 Million - $4.86 Million	288,700 New	288,700 $1.22 Million
Q2 2022 Aug 09, 2022	SELL	$3.94 - $11.77 $40,188 - $120,054	-10,200 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$5.9 - $9.45 $207,680 - $332,640	-35,200 Reduced 77.53%	10,200 $62,000
Q4 2021 Feb 10, 2022	BUY	$8.69 - $12.48 $394,526 - $566,592	45,400 New	45,400 $416,000
Q2 2021 Aug 13, 2021	SELL	$9.85 - $16.46 $518,612 - $866,635	-52,651 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.71 - $24.31 $202,737 - $387,768	15,951 Added 43.46%	52,651 $744,000
Q4 2020 Feb 12, 2021	SELL	$7.84 - $14.22 $156,016 - $282,978	-19,900 Reduced 35.16%	36,700 $414,000
Q3 2020 Nov 13, 2020	BUY	$9.93 - $33.26 $562,038 - $1.88 Million	56,600 New	56,600 $747,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

Black Rock Inc. New York, NY

5.32M
Shares

$40.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.98M
Shares

$38.2 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

3.88M
Shares

$29.7 Million
0.01% of portfolio
State Street Corp Boston, MA

3.41M
Shares

$26.2 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.75M
Shares

$21.1 Million
1.44% of portfolio

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $376M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Account